Anemia and cancer in older persons

Journal of Supportive Oncology

Volumn 5, Issue 3, 2007, Pages 107-113

  Penninx, Brenda W ^a   Cohen, Harvey Jay ^b   Woodman, Richard C ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Ortho Biotech Products LP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLATINUM COMPLEX; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BONE MARROW SUPPRESSION; CANCER; CANCER STAGING; CANCER SURVIVAL; COGNITIVE DEFECT; COMMUNITY LIVING; COMORBIDITY; DISABILITY; DISEASE ASSOCIATION; ELDERLY CARE; ERYTHROCYTE TRANSFUSION; FALLING; FATIGUE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GERIATRIC PATIENT; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEMOGLOBIN DETERMINATION; HOSPITALIZATION; HUMAN; LUNG CANCER; MORTALITY; NURSING HOME; NUTRITIONAL DEFICIENCY; PHYSICAL ACTIVITY; PREVALENCE; PROGNOSIS; PROSTATE CANCER; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CANCER; WELLBEING;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANEMIA; CLINICAL TRIALS; HUMANS; NEOPLASMS; PROGNOSIS; RISK FACTORS;

EID: 34249084602     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. American Cancer Society. Cancer Facts and Figures 2005. Available at:http.//www.cancer.org/do-croot/STT/stt_0.asp. Accessed December 15, 2005.
2. Balducci L. Anemia, cancer, and aging. Cancer Control 2003;10:478-486.[14552524]
3. Rao A, Cohen HJ. Symptom management in the elderly cancer patient: fatigue, pain, and depression. J Natl Cancer Inst Monogr 2004;32:150-157.[15263059]
4. National Cancer Institute. SEER database results. Available at: http:// seer.cancer.gov/csr/1975_2003/results⋯rged/topic∥evalence.pdf. Accessed July 12, 2006.
5. Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004;40:2293-2306. [15454256]
6. Birgegard G, Aapro MS, Bokemeyer C, et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology 2005;68(suppl 1):3-11. [15855811]
7. Barrett-Lee P, Bokemeyer C, Gascon P, et al; ECAS Advisory Board and Participating Centers. Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey. Oncologist 2005;10:743-757.[16249356]
8. Spivak JL. The anaemia of cancer: death by a thousand cuts. Nat Rev Cancer 2005;5:543-555. [15965494]
9. Maccio A, Madeddu C, Massa D, etal. Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia. Blood 2005;106:362-367.[15774616]
10. Repetto L. Greater risks of chemotherapy toxicity in elderly patients with cancer. J Support Oncol 2003;1(suppl 2):18-24.[15346996]
11. Beghe C, Wilson A, Ershler WB. Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med 2004;116(suppl 7A):3S-1OS.[15050882]
12. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004;104:2263-2268.[15238427]
13. Fleming DJ, Jacques PF, Tucker KL, et al. Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr 2001;73:638-646.[11237843]
14. Denny SG, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med 2006;119:327-334. [16564775]
15. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-1023. [15758012]
16. Smith DL. Anemia in the elderly. Am Fam Physician 2000;62:1565-1572.[11037074]
17. Ershler WB. Biological interactions of aging and anemia: a focus on cytokines. J Am Geriatr Soc 2003;51 (suppl 3):S18-S21.[12588568]
18. Chaves PH, Xue QL, Guralnik JM, Ferrucci L, Volpato S, Fried LP. What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J Am Geriatr Soc 2004;52:1811-1816. [15507056]
19. Penninx BW, Guralnik JM, Onder G, Ferrucci L, Wallace RB, Pahor M. Anemia and decline in physical performance among older persons. Am J Med 2003;115:104-110.[12893395]
20. Dharmarajan TS, Norkus EP. Mild anemia and the risk of falls in older adults from nursing homes and the community. J Am Med Dir Assoc 2004;5:395-400. [15530178]
21. Penninx BW, Pluijm SM, Lips P, et al. Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc 2005;53:2106-2111. [16398894]
22. Penninx BW, Pahor M, Cesari M, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 2004;52:719-724.[15086651]
23. Cesari M, Penninx BW, Lauretani F, et al. Hemoglobin levels and skeletal muscle: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004;59:249-254.[15031309]
24. Argyriadou S, Vlachonikolis I, Melisopoulou H, Katachanakis K, Lionis C. In what extent anemia coexists with cognitive impairment in elderly: a cross-sectional study in Greece. BMC Fam Pract 2001;2:5. [11707152]
25. Chaves PH, Carlson MC, Fried LP. Cognitive function in high functioning older women: does hemoglobin concentration matter? J Am Geriatr Soc 2002;50(suppl 4):S149-S150.
26. Zamboni V, Cesari M, Zuccala G. Anemia and cognitive performance in hospitalized older patients: results from the GIFA Study. Int J Geriatr Psychiatry 2006;21:529-534.[16783797]
27. Stafford RS, Cyr PL. The impact of cancer on the physical function of the elderly and their utilization of health care. Cancer 1997;80:1973-1980.[9366301]
28. Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 2004;116(suppl 7A):11S-26S. [1505883]
29. Aoe K, Hiraki A, Maeda T, et al. Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer. Intern Med 2005;44:800-804.[16157976]
30. Berardi R, Brunelli A, Tamburrano T, et al. Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers. Lung Cancer 2005;49:371-376.[15951051]
31. Dunst J, Kuhnt T, Strauss HG, et al. Anemia in cervical cancers: impact on survival, patterns of relapse,and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 2003;56:778-787. [12788185]
32. Citterio G, Bertuzzi A,Tresoldi M, et al. Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients. Eur Urol 1997;31:286-291.[9129917]
33. Shen JG, Cheong JH, Hyung WJ, et al. Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer. J Surg Oncol 2005;91:126-130.[16028285]
34. Lee WR, Berkey B, Marcial V, et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998;42:1069-1075.[9869231]
35. Beer TM, Tangen CM, Bland LB,Thompson IM, Crawford ED. Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of Southwest Oncology Group Study 8894. J Urol 2004;172:2213-2217.[15538234]
36. Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 2005;104:1998-2005.[16206252]
37. Montazeri A, Gillis CR, McEwen J. Quality of life in patients with lung cancer: a review of literature from 1970 to 1995. Chest 1998;113:467-481. [9498968]
38. Garman KS, Cohen HJ. Functional status and the elderly cancer patient. Crit Rev Oncol Hematol 2002;43:191-208.[12270776]
39. Balducci L, Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 2000;35:147-154.[10960797]
40. Abernethy AP, Shelby-James T, Fazekas BS, Woods D, Currow DC. The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]. BMC Palliat Care 2005;4:7. [16283937]
41. Michael M, Tannock IF. Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. CMAJ 1998;158:1727-1734.[9676550]
42. Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996;32A:1135-1141. [8758243]
43. Extermann M. Geriatric assessment with focus on instrument selectivity for outcomes. Cancer J 2005;11:474-480.[16393481]
44. Guttmann CR, Benson R, Warfield SK, et al. White matter abnormalities in mobility-impaired older persons. Neurology 2000;54:1277-1283. [10746598]
45. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332:556-561. [7838189]
46. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85-M94. [8126356]
47. Cella D.The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 1997;34(suppl 2):13-19. [9253774]
48. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997;13:63-74.[9095563]
49. Cohen HJ, Feussner JR, Weinberger M, et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med 2002;346:905-912.[11907291]
50. Brown DJ, McMillan DC, Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 2005;103:377-382.[15558809]
51. Mancuso A, Migliorino M, De Santis S, Saponiero A, De Marinis F. Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol 2006;17:146-150.[16251202]
52. Henry DH. Optimizing the treatment of anemia in cancer patients: the role of a new erythropoietic agent. Oncology (Williston Park) 2002;16(suppl 11):9-12.[12435168]
53. Navarrete Aleman J, Onate Ocana LF, Herrera Goepfert R, et al. Survival prognostic factors in a cohort of patients with esophageal carcinoma [in Spanish]. Rev Gastroenterol Mex 2004;69:209-216. [15765972]
54. Cella D. The effects of anemia and anemia treatment on the quality of life of people with cancer. Oncology (Williston Park) 2002;16(suppl 10]:125-132. [12380962]
55. Osterborg A, Brandberg Y, Molostova V, et al; Epoetin Beta Hematology Study Group. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies. J Clin Oncol 2002;20:2486-2494. [12011126]
56. Waltzman R, Croot C, Justice GR, et al. Randomized comparison of epoetin alfa (40,000 units weekly) and darbepoetin alfa (200 mcg every 2 weeks) in anemic patients with cancer receiving chemotherapy. Oncologist 2005;10:642-650.[16177289]
57. Schwartzberg LS, Yee LK, Senecal FM, et al. A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer. Oncologist 2004;9:696-707.[15561813]
58. Shasha D, George MJ, Harrison LB. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy. Cancer 2003;98:1072-1079.[12942577]
59. Gabrilove JL, Cleeland CS, Livingston RB, et al. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 2001;19:2875-2882. [11387360]
60. Kunikane H, Watanabe K, Fukuoka M, et al. Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer. Int J Clin Oncol 2001;6:296-301. [11828949]
61. Iconomou G, Koutras A, Rigopoulos A, Vagenakis AG, Kalofonos HP. Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial. J Pain Symptom Manage 2003;25:512-518.[12782431]
62. Tsukuda M, Yuyama S, Kohno H, et al. Effectiveness of weekly subcutaneous recombinant human erythropoietin administration for chemotherapy-induced anemia. Biotherapy 1998;11:21-25.[9617462]
63. Aapro MS, Kohne CH, Cohen HJ, Extermann M. Never too old? Age should not be a barrier to enrollment in cancer clinical trials. Oncologist 2005;10:198-204.[15793223]
64. Jatoi A, Hiliman S, Stella P, et al. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol 2005;23:9113-9119.[16361618]
65. Cascinu S, Del Ferro E, Fedeli A, et al. Recombinant human erythropoietin treatment in elderly cancer patients with cisplatin-associated anemia. Oncology 1995;52:422-426.[7637961]
66. Aapro MS, Dale DC, Blasi M, et al. Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy. Support Care Cancer 2006;14:1184-1194. [16758175]
67. Lichtman SM. Management of advanced colorectal cancer in older patients. Oncology 2005;19:597-602.[15945341]
68. Cravens DD. Comprehensive geriatric assessment for non-geriatricians. Mo Med 2006;103:157-160.[16703716]
69. Dale DC. Poor prognosis in elderly patients with cancer: the role of bias and undertreatment. J Support Oncol 2003;1(suppl 2):11-17.[15346995]
70. Villela L,Sureda A, Canals C, et al. Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation. Haematologica 2003;88:300-305. [12651269]
71. Dunn A, Carter J, Carter H. Anemia at the end of life: prevalence, significance, and causes in patients receiving palliative care. J Pain Symptom Manage 2003;26:1132-1139.[14654265]
72. Wildiers H, Highley MS, de Bruijn EA, van Oosterom AT. Pharmacology of anticancer drugs in the elderly population. Clin Pharmacokinet 2003;42:1213-1242.[14606930]
73. Carbone PP. Advances in the systemic treatment of cancers in the elderly. Crit Rev Oncol Hematol 2000;35:201-218.[10960801]